Author

Eleanore Hendrickson

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Combined type 2 cytokine blockade enhances PD-1-mediated antitumor immunity.

Immune checkpoint inhibitors improve outcomes for many patients with cancer, but resistance remains a major clinical challenge. Type 2 cytokines, including IL-4, IL-13, and thymic stromal lymphopoietin (TSLP), have been implicated in suppressing anti-tumor immunity. Here, we investigated whether combined blockade of IL...

T. Fabre, Eleanore Hendrickson, K. McGourty et al. · Cell Reports · 0 citations